DexCom Profile

56.75
USD 1.47  2.52%
52.25Last Month High 58.6 
55.87Trading Day  High 58.22 

Exercise or conversion by John Lister of 1750 shares of DexCom subject to Rule 16b-3

DexCom Inc insider trading alert for exercise of non-qualified stock option (right to buy) by John Lister, Sr. VP General Counsel, on January 15, 2018. This event was filed by Dexcom Inc with SEC on 2014-07-15. Statement of changes in beneficial ownership - SEC Form 4. John Lister is currently serves as senior vice president general counsel of DexCom Inc [view details]   

DexCom Summary

DexCom Inc (DXCM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 1,212 people. DexCom is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 5.06 B. DexCom Inc conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 86.9 M outstanding shares of which 12.17 M shares are currently shorted by private and institutional investors with about 7.5 trading days to cover. DEXCOM currently holds about 525.8 M in cash with 64.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05.
Check DexCom Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected DexCom Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DexCom Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 3% 
Equity ratings for DexCom Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameDexCom Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Equipment
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCALIFORNIA, U.S.A
Business Address6340 Sequence Drive, San Diego, CA 92121, United States
ExchangeNASDAQ
CIK Number01093557.0
ISINUS2521311074
CUSIP252131107
SectorHealthcare
IndustryMedical Equipment
BenchmarkDOW
Websitewww.dexcom.com
Contact Number858 200 0201
CurrencyUSD - US Dollar

Recommendations

DexCom Analyst Recommendations
Target PriceAdvice# of Analysts
85.31Buy16Odds
DexCom Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
DexCom Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

DexCom Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.18April 26, 2017
DexCom Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate